Harmony Biosciences Holdings (HRMY) Non-Current Assets (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Non-Current Assets data on file, last reported at $493.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 19.42% year-over-year to $493.0 million; the trailing twelve-month figure through Mar 2026 stood at $493.0 million (up 19.42% YoY), and the FY2025 full-year result was $364.6 million, down 13.18% from the prior year.
• Non-Current Assets improved to $493.0 million in Q1 2026, from $364.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $493.0 million in Q1 2026 to a low of $182.3 million in Q2 2022.
• A 5-year average of $342.8 million and a median of $364.6 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 83.61% in 2022 and slipped 13.18% in 2025, its largest moves.
• Tracing HRMY's Non-Current Assets over 5 years: stood at $273.6 million in 2022, then soared by 31.72% to $360.4 million in 2023, then advanced by 16.53% to $419.9 million in 2024, then slipped by 13.18% to $364.6 million in 2025, then surged by 35.21% to $493.0 million in 2026.
• Business Quant data shows HRMY's Non-Current Assets at $493.0 million in Q1 2026, $364.6 million in Q4 2025, and $369.4 million in Q3 2025.